📢 LOTTE BIOLOGICS at IMAPAC | Biologics Manufacturing Korea 2025 Come meet us at IMAPAC's biopharmaceutical manufacturing conference with two talks from our LOTTE BIOLOGICS team: https://lnkd.in/g_ehWWFK 📅 Sept 25-26 📍 Songdo Convensia, Incheon 🕟 Day 1 | 15:40~16:05 Jonggu Kim, Director, Quality Topic: Root Cause Analysis for GMP Nonconformities and CAPA Management 🕚 Day 2 | 11:15~11:40 Hyemi Kim, Head of IT Topic: Bioprocessing 4.0: Shaping the Future of Smart & Connected Biomanufacturing These talks connect the dots between root-cause analysis, CAPA effectiveness checks, and real-time data with digitally connected operations - the same playbook we use at our Syracuse Bio Campus today and that we will extend to our Songdo Bio Campus! We hope to see you there! #IMAPAC #BMK2025 #LOTTEBIOLOGICS #Biomanufacturing #GMP #CAPA #Quality #Bioprocessing40 #DigitalTransformation #SmartManufacturing #DataIntegrity #Korea #Songdo
About us
Headquartered in Seoul, South Korea, LOTTE BIOLOGICS was founded in 2022 with a mission to deliver therapies that contribute to a healthier world. At the Syracuse Bio Campus in New York, LOTTE BIOLOGICS provides high-quality GMP manufacturing services for drug substances. The facility offers a total production capacity of 40,000L, supported by eight 5,000L stainless steel bioreactors. Additionally, the campus includes extensive analytical QC testing laboratories and warehouse facilities that have received over 62 regulatory approvals from agencies worldwide. LOTTE BIOLOGICS is also advancing into a new area of expertise with Antibody-Drug Conjugates (ADCs) services. With over $100 million invested in ADC modalities, including both drug substance and conjugation capabilities on-site, we offer a seamless, end-to-end service from drug substance manufacturing to conjugation. Looking ahead, LOTTE BIOLOGICS is constructing three advanced bio plants in Songdo, South Korea. With construction of the first plant already underway and expected to be operational by 2027, each facility will feature eight 15,000L stainless steel bioreactors for large-scale commercial production, along with multiple 3,000L bioreactors to meet clinical production needs. Collectively, these plants will provide a manufacturing volume exceeding 360,000L in bioreactor capacity. Through our commitment to delivering innovative medicines to patients worldwide, LOTTE BIOLOGICS aims to become a top-tier global CDMO company in the biopharmaceutical industry.
- Website
-
https://www.lottebiologics.com/en
External link for LOTTE BIOLOGICS
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Seoul
- Type
- Privately Held
- Founded
- 2022
Locations
-
Primary
300, Olympic-ro, Songpa-gu
Seoul, KR
-
6000 Thompson Rd
East Syracuse, New York 13057, US
-
418, Songdo-dong, Yeonsu-gu
Incheon, 406840, KR
-
1 Broadway
Cambridge, Massachusetts 02142, US
Employees at LOTTE BIOLOGICS
Updates
-
🏆 Recognized by Korea’s Ministry of Employment and Labor (MOEL) We’re honored to share two government recognitions for LOTTE BIOLOGICS: Sept 15, 2025 — Government Commendation for Contributions to Job Creation — Prime Minister’s Commendation Sept 11, 2025 — 2025 Korea Best Job Company Certification 롯데바이오로직스가 지난 11일 ‘2025 대한민국 일자리 으뜸기업’ 선정에 이어, 15일 ‘2025년 일자리 창출 유공 정부포상 전수식’에서 일자리 창출 지원 부문 국무총리 표창을 수상했습니다. 롯데바이오로직스는 양질의 일자리 제공·인재 양성·안정적이고 일하기 좋은 환경에 꾸준히 투자하며 실행해 나가겠습니다. 사람이 성장하는 회사, 그 성장이 다시 더 좋은 일자리를 만드는 선순환을 이어가겠습니다. 📌 기사 전문 보기: https://lnkd.in/gkCaefBw We’ll continue to invest in talent development, create quality jobs, and build a stable, great place to work. #LOTTEBIOLOGICS #MOEL #JobCreation #PrimeMinistersCommendation #PeopleFirst #Workplace #Korea #일자리창출 #일자리으뜸기업인증
-
-
🧡 World Patient Safety Day | Sept 17, 2025 As we manufacture life changing medications for patients worldwide, we believe that patient safety is paramount! At LOTTE BIOLOGICS, patient safety starts upstream - through robust quality systems, data integrity, contamination control strategy, and cGMP manufacturing discipline. Let's light the world orange and advance a culture of patient safety-together. #WorldPatientSafetyDay #WPSD2025 #PatientSafety #Quality #cGMP #DataIntegrity #Biomanufacturing #LOTTEBIOLOGICS
-
-
🎉 LOTTE BIOLOGICS hits 20,000 on LinkedIn! Thank you for being with us on every step of our journey. Here's to many more exciting milestones and developments! #LOTTEBIOLOGICS #CDMO #Biomanufacturing #ADC #Innovation
-
-
🌐 BIO Japan 2025 | LOTTE BIOLOGICS バイオジャパン2025 | ロッテバイオロジクス BIO Japan brings together global biotech leaders to move therapies from discovery to delivery. At LOTTE BIOLOGICS, we support mAb and ADC programs with our development expertise and cGMP manufacturing at our Syracuse campus-helping innovation scale up with confidence. For the future, we are building a biomanufacturing platform designed not only to meet today's standards, but to set tomorrow's. With bold science and responsible stewardship, we are shaping a future where innovation can scale up without compromise. We look forward to meeting you onsite! 会場にて皆様にお会いできることを心よりお待ちしております。 📅 Oct 8-10 📍 PACIFICO Yokohama - Booth #C-57 💬 On the BIO Japan 2025 partnering page, please search "LOTTE BIOLOGICS." 💬 BIO Japanのパートナリングページ内にて「LOTTE BIOLOGICS」をご検索下さい。 #BIOJapan2025 #LOTTEBIOLOGICS #CDMO #Biomanufacturing #mAbs #ADCs #Innovation
This content isn’t available here
Access this content and more in the LinkedIn app
-
🏗️ Topping-Out at Songdo | LOTTE BIOLOGICS We’re excited to mark the topping-out of Plant 1 at our Songdo Bio Campus—the structural frame was completed just 18 months after groundbreaking. We’re on track for completion in 2026 and commercial production in 2027. Strengthening our dual-site model with Syracuse, NY (mAb, ADC) and Plant 1 in Songdo, Korea, (commercial-scale mAb, smart-factory design) advances our flexible CDMO capabilities for clients worldwide. 📌 Read the full release: https://lnkd.in/gxPt4sAQ #LOTTEBIOLOGICS #CDMO #Biomanufacturing #Songdo #Syracuse #ManufacturingExcellence
-
-
Celebrating Our Culture at LOTTE BIOLOGICS 🌿 At LOTTE BIOLOGICS, we believe that a positive and collaborative culture starts with open communication. Last week, our LBK Junior Board hosted the event, offering snacks and a coffee truck on-site at our office to connect with colleagues and create meaningful moments together. ☕🍪 🔹 What is the Junior Board? The Junior Board was created to foster an inclusive and collaborative workplace by: - Sharing ideas and driving improvements for a positive organizational culture - Promoting open communication and team bonding across the company 🔹 Our Motto - Look at Me (날 봐): Introducing ourselves and our teams - Look at You (널 봐): Understanding one another through dialogue - Look at Us (우릴 봐): Building harmony and unity among everyone Through events like this, we continue to strengthen connections across teams and celebrate the vibrant culture that drives us forward. #LOTTEBIOLOGICS #JuniorBoard #CompanyCulture #Teamwork #EmployeeEngagement
-
-
✨ Another first for LOTTE BIOLOGICS - the launch of our very first Employee Resource Group at the Syracuse campus: WISE (Women Inspiring Success & Excellence) 🌿 Created after listening to employee feedback, WISE was designed to: Empower women across our organization Connect employees through shared experiences Foster a space for learning, mentorship, and community Our mission focuses on career development, well-being, mentorship, and community engagement - and this is just the beginning. 🚀 #OneLOTTEBIOLOGICS #WISE #SyracuseCampus #WomenLeadership #DiversityAndInclusion #EmployeeExperience #LOTTEBIOLOGICS
-
-
🌎 Expanding Global Partnerships | LOTTE BIOLOGICS We are excited to announce another milestone at LOTTE BIOLOGICS! We've secured our third major contract in 2025 through a late-stage to commercial manufacturing partnership with a leading U.S.-based biopharmaceutical company. Leveraging our dual-site operations in Syracuse, NY and Songdo, Korea, and combining one of the largest conjugation capacities in the U.S. with our integrated quality system, LOTTE BIOLOGICS continues to deliver bold science and dependable manufacturing solutions globally. 📌 Read the full article here: https://lnkd.in/gwDwnw6e #LOTTEBIOLOGICS #CDMO #GlobalPartnership #Biomanufacturing #Innovation #BiotechLeadership
-
-
📢 LOTTE BIOLOGICS at ISPE Singapore 2025 We were honored to have Dr. Hyungduk Yoo (COO, Business Expansion Division) represent LOTTE BIOLOGICS at the ISPE Singapore Conference & Exhibition 2025 on August 28. During his session, "Quality Through Both Lenses: Bridging Client and CDMO Expectations", Dr. Yoo highlighted how transparent communication with clients plays a critical role in aligning external and internal quality standards - especially when overcoming operational challenges. Following the presentation, Dr. Yoo also joined a panel discussion where he shared insights on building long-term, trust-based partnerships through open collaboration and shared quality goals. We are proud to contribute to shaping the conversation around quality excellence and stronger client-CDMO partnerships in biomanufacturing. Discover more about our ADC capabilities: https://lnkd.in/gJGEpXmz #LOTTEBIOLOGICS #ISPESingapore #ISPE2025 #CDMO #QualityExcellence #Biomanufacturing #ClientPartnerships #OperationalExcellence
-